Loss of basement membrane heparan sulfate expression is associated with tumor progression in endometrial cancer

Hasengaowa, J. Kodama, T. Kusumoto, Y. Shinyo, N. Seki, Keiichiro Nakamura, A. Hongo, Y. Hiramatsu

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Perlecan is a major heparan sulfate proteoglycan (HPSG) of the basement membrane (BM) and binds to various cytokines and growth factors via its heparan sulfate glycosaminoglycan (HS-GAG) chains. The aim of this study was to investigate BM HS-GAG expression in endometrial cancers. We investigated the expression of BM HS-GAG by immunohistochemistry in 109 endometrial cancers and analyzed correlations with various clinicopathological features. The HS-GAG expression index was significantly lower in cases of advanced stage, high-grade, deep myometrial invasion, positive peritoneal cytology, lymph vascular space invasion and lymph node metastasis. There was no association between HS-GAG expression status and patient outcome. Decreased HS-GAG expression of BM is associated with tumor progression, but is not be a useful prognostic factor in patients presenting with endometrial cancer.

Original languageEnglish
Pages (from-to)403-406
Number of pages4
JournalEuropean Journal of Gynaecological Oncology
Volume26
Issue number4
Publication statusPublished - 2005

Fingerprint

Heparitin Sulfate
Endometrial Neoplasms
Glycosaminoglycans
Basement Membrane
Neoplasms
Heparan Sulfate Proteoglycans
Lymph
Blood Vessels
Cell Biology
Intercellular Signaling Peptides and Proteins
Lymph Nodes
Immunohistochemistry
Cytokines
Neoplasm Metastasis

Keywords

  • Basement membrane
  • Endometrial cancer
  • Heparan sulfate

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Oncology

Cite this

Loss of basement membrane heparan sulfate expression is associated with tumor progression in endometrial cancer. / Hasengaowa; Kodama, J.; Kusumoto, T.; Shinyo, Y.; Seki, N.; Nakamura, Keiichiro; Hongo, A.; Hiramatsu, Y.

In: European Journal of Gynaecological Oncology, Vol. 26, No. 4, 2005, p. 403-406.

Research output: Contribution to journalArticle

Hasengaowa, Kodama, J, Kusumoto, T, Shinyo, Y, Seki, N, Nakamura, K, Hongo, A & Hiramatsu, Y 2005, 'Loss of basement membrane heparan sulfate expression is associated with tumor progression in endometrial cancer', European Journal of Gynaecological Oncology, vol. 26, no. 4, pp. 403-406.
Hasengaowa ; Kodama, J. ; Kusumoto, T. ; Shinyo, Y. ; Seki, N. ; Nakamura, Keiichiro ; Hongo, A. ; Hiramatsu, Y. / Loss of basement membrane heparan sulfate expression is associated with tumor progression in endometrial cancer. In: European Journal of Gynaecological Oncology. 2005 ; Vol. 26, No. 4. pp. 403-406.
@article{a55c32a0a95b4feb99ca8c288ad33174,
title = "Loss of basement membrane heparan sulfate expression is associated with tumor progression in endometrial cancer",
abstract = "Perlecan is a major heparan sulfate proteoglycan (HPSG) of the basement membrane (BM) and binds to various cytokines and growth factors via its heparan sulfate glycosaminoglycan (HS-GAG) chains. The aim of this study was to investigate BM HS-GAG expression in endometrial cancers. We investigated the expression of BM HS-GAG by immunohistochemistry in 109 endometrial cancers and analyzed correlations with various clinicopathological features. The HS-GAG expression index was significantly lower in cases of advanced stage, high-grade, deep myometrial invasion, positive peritoneal cytology, lymph vascular space invasion and lymph node metastasis. There was no association between HS-GAG expression status and patient outcome. Decreased HS-GAG expression of BM is associated with tumor progression, but is not be a useful prognostic factor in patients presenting with endometrial cancer.",
keywords = "Basement membrane, Endometrial cancer, Heparan sulfate",
author = "Hasengaowa and J. Kodama and T. Kusumoto and Y. Shinyo and N. Seki and Keiichiro Nakamura and A. Hongo and Y. Hiramatsu",
year = "2005",
language = "English",
volume = "26",
pages = "403--406",
journal = "European Journal of Gynaecological Oncology",
issn = "0392-2936",
publisher = "S.O.G. CANADA Inc.",
number = "4",

}

TY - JOUR

T1 - Loss of basement membrane heparan sulfate expression is associated with tumor progression in endometrial cancer

AU - Hasengaowa,

AU - Kodama, J.

AU - Kusumoto, T.

AU - Shinyo, Y.

AU - Seki, N.

AU - Nakamura, Keiichiro

AU - Hongo, A.

AU - Hiramatsu, Y.

PY - 2005

Y1 - 2005

N2 - Perlecan is a major heparan sulfate proteoglycan (HPSG) of the basement membrane (BM) and binds to various cytokines and growth factors via its heparan sulfate glycosaminoglycan (HS-GAG) chains. The aim of this study was to investigate BM HS-GAG expression in endometrial cancers. We investigated the expression of BM HS-GAG by immunohistochemistry in 109 endometrial cancers and analyzed correlations with various clinicopathological features. The HS-GAG expression index was significantly lower in cases of advanced stage, high-grade, deep myometrial invasion, positive peritoneal cytology, lymph vascular space invasion and lymph node metastasis. There was no association between HS-GAG expression status and patient outcome. Decreased HS-GAG expression of BM is associated with tumor progression, but is not be a useful prognostic factor in patients presenting with endometrial cancer.

AB - Perlecan is a major heparan sulfate proteoglycan (HPSG) of the basement membrane (BM) and binds to various cytokines and growth factors via its heparan sulfate glycosaminoglycan (HS-GAG) chains. The aim of this study was to investigate BM HS-GAG expression in endometrial cancers. We investigated the expression of BM HS-GAG by immunohistochemistry in 109 endometrial cancers and analyzed correlations with various clinicopathological features. The HS-GAG expression index was significantly lower in cases of advanced stage, high-grade, deep myometrial invasion, positive peritoneal cytology, lymph vascular space invasion and lymph node metastasis. There was no association between HS-GAG expression status and patient outcome. Decreased HS-GAG expression of BM is associated with tumor progression, but is not be a useful prognostic factor in patients presenting with endometrial cancer.

KW - Basement membrane

KW - Endometrial cancer

KW - Heparan sulfate

UR - http://www.scopus.com/inward/record.url?scp=23744468224&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23744468224&partnerID=8YFLogxK

M3 - Article

C2 - 16122188

AN - SCOPUS:23744468224

VL - 26

SP - 403

EP - 406

JO - European Journal of Gynaecological Oncology

JF - European Journal of Gynaecological Oncology

SN - 0392-2936

IS - 4

ER -